Shiro Mori

3.3k total citations
123 papers, 2.6k citations indexed

About

Shiro Mori is a scholar working on Oncology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Shiro Mori has authored 123 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 37 papers in Biomedical Engineering and 25 papers in Molecular Biology. Recurrent topics in Shiro Mori's work include Ultrasound and Hyperthermia Applications (26 papers), Cancer Cells and Metastasis (22 papers) and Lymphatic System and Diseases (19 papers). Shiro Mori is often cited by papers focused on Ultrasound and Hyperthermia Applications (26 papers), Cancer Cells and Metastasis (22 papers) and Lymphatic System and Diseases (19 papers). Shiro Mori collaborates with scholars based in Japan, United States and Canada. Shiro Mori's co-authors include Tetsuya Kodama, Maya Sakamoto, Sachiko Horie, Masato Nose, Shigekí Kato, Keiichi Saito, Yukiko Watanabe, Naoko Tanda, K. Takeda and Seizaburo Sakamoto and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer.

In The Last Decade

Shiro Mori

116 papers receiving 2.6k citations

Peers

Countries citing papers authored by Shiro Mori

Since Specialization

Citations

This map shows the geographic impact of Shiro Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Mori more than expected).

Fields of papers citing papers by Shiro Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Mori. The network helps show where Shiro Mori may publish in the future.

Co-authorship network of co-authors of Shiro Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Mori. A scholar is included among the top collaborators of Shiro Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Mori. Shiro Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intralymphatic injection of chemotherapy drugs modulated with glucose improves their anticancer effect 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Shiro Mori, Kiyoto Shiga, Tetsuya Kodama	3
2	The Therapeutic Effect of Second Near-Infrared Absorbing Gold Nanorods on Metastatic Lymph Nodes via Lymphatic Delivery System 2021 ·Pharmaceutics ·Adewale O. Oladipo, Thabang Calvin Lebepe, (unknown), Ncediwe Tsolekile, Sundararajan Parani, Sandile P. Songca, Shiro Mori, Tetsuya Kodama, Oluwatobi S. Oluwafemi	8
3	Optimization of the delivery of molecules into lymph nodes using a lymphatic drug delivery system with ultrasound 2021 ·International Journal of Pharmaceutics ·Shigekí Kato, (unknown), Shiro Mori, Tetsuya Kodama	3
4	Tumor cell invasion from the marginal sinus into extranodal veins during early-stage lymph node metastasis can be a starting point for hematogenous metastasis 2018 ·Journal of Cancer Metastasis and Treatment ·Tetsuya Kodama, Shiro Mori, Masato Nose	16
5	Activation of lung metastasis after lymph node dissection 2018 ·Annals of Oncology ·(unknown), (unknown), Shiro Mori, Tomonobu Kodama	1
6	Evaluation of metastatic niches in distant organs after surgical removal of tumor-bearing lymph nodes 2018 ·BMC Cancer ·Jinhua Zheng, Limin Jia, Shiro Mori, Tetsuya Kodama	21
7	Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL- Fas ^lpr mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κ B 2015 ·Autoimmunity ·Keiichi Saito, Shiro Mori, Fumiko Date, Guang Hong	15
8	Targeting of tumor endothelial cells combining 2 Gy/day of X‐ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors 2014 ·Cancer Medicine ·Yoshikazu Kuwahara, (unknown), Shuji Kitahara, Motoi Fukumoto, Taichi Ezaki, Shiro Mori, Seishi Echigo, Yasuhito Ohkubo, (unknown), (unknown)	24
9	Guanine nucleotide‐binding protein 1 is one of the key molecules contributing to cancer cell radioresistance 2014 ·Cancer Science ·Motoi Fukumoto, (unknown), Yoshikazu Kuwahara, Tsutomu Shimura, Masatoshi Suzuki, Shiro Mori, Hiroyuki Kumamoto, Yohei Saito, Yasuhito Ohkubo, Zhenfeng Duan, Kenji Sano, Tomohiro Oguchi, (unknown), Shin‐ichi Usami, Kengo Kinoshita, Inchul Lee, (unknown), (unknown)	31
10	Mouse Model of Lymph Node Metastasis via Afferent Lymphatic Vessels for Development of Imaging Modalities 2013 ·PLoS ONE ·Li Li, Shiro Mori, Maya Sakamoto, Shoki Takahashi, Tetsuya Kodama	51
11	Herpes Simplex Virus Thymidine Kinase-Mediated Suicide Gene Therapy Using Nano/Microbubbles and Ultrasound 2007 ·Ultrasound in Medicine & Biology ·(unknown), Yukiko Watanabe, Shiro Mori, Masahiko Takahashi, Georges Vassaux, Tetsuya Kodama	54
12	A Signal Adaptor SLAM-Associated Protein Regulates Spontaneous Autoimmunity and Fas-Dependent Lymphoproliferation in MRL- Fas lpr Lupus Mice 2006 ·The Journal of Immunology ·(unknown), Hiroshi Furukawa, Shiro Mori, Mitsuko R. Ito, Miho Terada, (unknown), Naoto Ishii, (unknown), Masato Nose, Masao Ono	50
13	Genetic characterisation of spontaneous ankylosing arthropathy with unique inheritance from Fas-deficient strains of mice 2006 ·Annals of the Rheumatic Diseases ·Shiro Mori, (unknown), Naoko Tanda, Fumiko Date, Masato Nose, Hiroshi Furukawa, Masao Ono	4
14	Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice 2005 ·European Journal of Immunology ·Tatsuhiko Miyazaki, Masao Ono, Wei‐Min Qu, Mingcai Zhang, Shiro Mori, Shuichi Nakatsuru, Yusuke Nakamura, Tatsuya Sawasaki, Yaeta Endo, Masato Nose	62
15	Uridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinoma 2002 ·Cancer ·Hitoshi Miyashita, Yuji Takebayashi, James F. Eliason, Fumihiro Fujimori, Yasutaka Nitta, Atsushi Satō, (unknown), Akira Ōhashi, (unknown), Manabu Fukumoto, Shiro Mori, Takafumi Uchida	22
16	Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies 2000 ·Journal of Oral Pathology and Medicine ·Naoko Tanda, Shiro Mori, Keiichi Saito, (unknown), Seizaburo Sakamoto	66
17	Anti‐cytoplasmic autoantibodies reactive with epithelial cells of the salivary gland in sera from patients with Sjögren's syndrome: their disease‐ and organ‐specificities 1999 ·Journal of Oral Pathology and Medicine ·Maya Sakamoto, Masaaki Miyazawa, Shiro Mori, Ryuichi Fujisawa	7
18	Lymphocytoma cutis involving the lower lip 1997 ·Contact Dermatitis ·(unknown), Setsuya Aiba, Shiro Mori, (unknown), Hachiro Tagami	7
19	Production of monoclonal antibodies reactive with a denatured form of the friend murine leukemia virus gp70 envelope protein: Use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting 1991 ·Journal of Virological Methods ·Michael Robertson, Masaaki Miyazawa, Shiro Mori, Byron Caughey, Leonard H. Evans, Stanley F. Hayes, Bruce Chesebro	106
20	Analysis of parvovirus infections using strand-specific hybridization probes 1989 ·Virus Research ·Marshall E. Bloom, Søren Alexandersen, Shiro Mori, James B. Wolfinbarger	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact